Quantitative analysis for Sutro Biopharma, Inc. (STRO) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (51.0) (grade C). Gem alpha score: 74.0. 34 signals analyzed (29 differentiated alt-data).
STRO stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-30 | $39.10 | $36.05 | $36.62 |
| 2026-05-12 | $41.26 | $37.73 | $40.91 |
| 2026-05-22 | $31.45 | $25.24 | $25.57 |
| 2026-06-04 | $30.94 | $27.00 | $28.68 |
| 2026-06-16 | $31.46 | $27.10 | $28.17 |
| 2026-06-29 | $34.05 | $30.48 | $33.35 |
| 2026-07-10 | $30.13 | $27.80 | $29.73 |
| 2026-07-22 | $24.92 | $22.79 | $23.40 |
| 2026-08-03 | $25.27 | $23.00 | $25.10 |
| 2026-08-13 | $22.00 | $21.01 | $21.31 |
| 2026-08-25 | $21.82 | $20.75 | $21.44 |
| 2026-09-04 | $20.43 | $19.86 | $20.07 |
How Sutro Biopharma, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| NAUT | Nautilus Biotechnology, Inc. | $302M | — |
| BCYC | Bicycle Therapeutics plc | $306M | — |
| STTK | Shattuck Labs, Inc. | $296M | — |
| SLN | Silence Therapeutics plc | $295M | — |
View all Health Care stocks by valuation and signals →
Sutro Biopharma, Inc. (STRO) scores Hold (51.0), and the composite conceals a 71-point disagreement between its dimensions. It is strongest on AI Alpha (gem) at 99 and earnings quality at 82, and weakest on ML forecast at 32 and technicals at 28. A stock can carry AI Alpha (gem) that high while technicals sits at 28; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| AI Alpha (gem) | 99 |
| earnings quality | 82 |
| competitive moat | 78 |
| analyst consensus | 52 |
| ML forecast | 32 |
| technicals | 28 |
StoQuant analyzes 34 signals (29 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Sutro Biopharma, Inc. (STRO): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/STRO"><img src="https://stoquant.com/badge/STRO.svg" alt="Sutro Biopharma, Inc. (STRO) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.